Nabriva Therapeutics Plc (NASDAQ: NBRV)
Some price data may be temporarily unavailable.
Nabriva Therapeutics Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nabriva Therapeutics Plc Company Info
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
News & Analysis
Why Nabriva Therapeutics Stock Is Falling Today
Shares dropped after the biotech reported what seemed like good news. What's going on?
3 Companies Tackling the Antibiotic-Resistant Bacteria Crisis
Paratek Corp., Nabriva Therapeutics, and Cempra all appear on course to bring new antibiotics to market soon. But which could be the best bet for your portfolio now?
Why Nabriva Therapeutics Shares Are Falling Today
The roller-coaster ride continues for this clinical-stage biotech's stock.
Here's Why Nabriva Therapeutics PLC Is Soaring Today
Analyst upgrades and news that the company's balance sheet is getting a makeover caused traders to cheer.
Why Nabriva Therapeutics PLC Is Skyrocketing
Shares soar after the company reports upbeat data from a pivotal clinical trial.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.